GC
MDT icon

Garde Capital’s Medtronic MDT Stock Holding History

Garde Capital’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-160
Closed -$13.9K – 576
2025
Q2 		$13.9K Buy
160
+100
+167% +$8.48K ﹤0.01% 476
2025
Q1 		$5.39K Buy
+60
New +$5.37K ﹤0.01% 538
2023
Q3 		– Sell
-5,760
Closed -$507K – 269
2023
Q2 		$507K Buy
+5,760
New +$496K 0.04% 138

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Garde Capital's MDT Position: Q3 2025 in Review

Garde Capital sold out of Medtronic (MDT) in Q3 2025, closing a stake of 160 shares — an estimated $13.9K sold.

Garde Capital first reported a position in MDT in Q2 2023 and held it in 3 quarters. The position peaked at $507K in Q2 2023. 2,169 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

  • Garde Capital reported no remaining Medtronic position as of Q3 2025 after selling out during the quarter.
  • Garde Capital sold 160 Medtronic shares in Q3 2025, an estimated $13.9K.
  • Garde Capital first reported a position in Medtronic in Q2 2023 and held it in 3 quarters.
  • Garde Capital's Medtronic position peaked at $507K in Q2 2023.
  • 2,169 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on Garde Capital's 13F filing for Q3 2025, filed 16 Dec 2025.